# Deep Track Capital, LP 13F holdings Q2 2026: $6.9 billion

Deep Track Capital, LP reported $6.9 billion in 13F securities across 67 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Guardant Health Inc at $509 million, 7.4% of the reported value. Since Q1 2026 it opened 19 new positions and exited 15.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $6,870,469,447
- Positions: 67
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1856083
- Form 13F file number: 028-21949
- Business address: 200 Greenwich Avenue 3rd Floor, Greenwich, CT 06830
- SEC filing: [0001856083-26-000004](https://www.sec.gov/Archives/edgar/data/1856083/000185608326000004/0001856083-26-000004-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/deep-track-capital-lp-312459)

## Top 25 holdings by value

The largest of 67 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Guardant Health Inc](https://specstream.ai/data/institutional-holders/guardant-health-inc-40131m109) | COM | 3,393,312 | $509.1 million | +55,071 |
| [Immunovant Inc](https://specstream.ai/data/institutional-holders/immunovant-inc-45258j102) | COM | 9,341,151 | $359.9 million | -2,185,820 |
| [Structure Therapeutics Inc](https://specstream.ai/data/institutional-holders/structure-therapeutics-inc-86366e106) | SPONSORED ADS | 4,740,072 | $254.4 million | +460,224 |
| [Vaxcyte Inc](https://specstream.ai/data/institutional-holders/vaxcyte-inc-92243g108) | COM | 4,300,000 | $250 million | No change |
| [Alnylam Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/alnylam-pharmaceuticals-inc-02043q107) | COM | 825,000 | $248.3 million | New |
| [Veradermics Inc](https://specstream.ai/data/institutional-holders/veradermics-inc-922967104) | COMMON STOCK | 2,000,000 | $245.9 million | +1,500,000 |
| [Tarsus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/tarsus-pharmaceuticals-inc-87650l103) | COM | 3,666,768 | $230.8 million | +66,768 |
| [Nuvalent Inc](https://specstream.ai/data/institutional-holders/nuvalent-inc-670703107) | COM | 1,783,322 | $220.2 million | +406,998 |
| [Alkermes PLC](https://specstream.ai/data/institutional-holders/alkermes-plc-g01767105) | SHS | 4,000,000 | $209.6 million | +409,677 |
| [Ocular Therapeutix Inc](https://specstream.ai/data/institutional-holders/ocular-therapeutix-inc-67576a100) | COM | 19,686,282 | $193.3 million | No change |
| [Biomarin Pharmaceutical Inc](https://specstream.ai/data/institutional-holders/biomarin-pharmaceutical-inc-09061g101) | COM | 3,307,481 | $189.3 million | +2,157,481 |
| [Nurix Therapeutics Inc](https://specstream.ai/data/institutional-holders/nurix-therapeutics-inc-67080m103) | COM | 7,736,455 | $187.7 million | +1,391,211 |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 1,926,000 | $183.3 million | -108,203 |
| [Alumis Inc](https://specstream.ai/data/institutional-holders/alumis-inc-022307102) | COM | 6,348,558 | $178.6 million | -424,037 |
| [Ionis Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ionis-pharmaceuticals-inc-462222100) | COM | 2,200,000 | $174.4 million | +250,000 |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 12,161,496 | $172.1 million | No change |
| [Vera Therapeutics Inc](https://specstream.ai/data/institutional-holders/vera-therapeutics-inc-92337r101) | CL A | 4,000,000 | $171.6 million | -106,067 |
| [Axsome Therapeutics Inc.](https://specstream.ai/data/institutional-holders/axsome-therapeutics-inc-05464t104) | COM | 700,000 | $171.3 million | -400,000 |
| [Genmab A/S](https://specstream.ai/data/institutional-holders/genmab-a-s-372303206) | SPONSORED ADS | 5,650,000 | $155.2 million | +1,986,750 |
| [Moonlake Immunotherapeutics](https://specstream.ai/data/institutional-holders/moonlake-immunotherapeutics-61559x104) | CLASS A ORD | 6,999,025 | $136.3 million | +590,162 |
| [Hemab Therapeutics Hldgs Inc](https://specstream.ai/data/institutional-holders/hemab-therapeutics-hldgs-inc-423494103) | COM SHS | 3,602,093 | $132.3 million | New |
| [Tango Therapeutics Inc](https://specstream.ai/data/institutional-holders/tango-therapeutics-inc-87583x109) | COM | 4,200,000 | $131.3 million | +1,450,000 |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 2,750,000 | $129.4 million | -250,000 |
| [Grail Inc](https://specstream.ai/data/institutional-holders/grail-inc-384747101) | COM | 1,834,944 | $125.3 million | +112,147 |
| [Bicara Therapeutics Inc](https://specstream.ai/data/institutional-holders/bicara-therapeutics-inc-055477103) | COM | 4,100,000 | $121.7 million | +37,500 |

## New positions in Q2 2026

19 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Alnylam Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/alnylam-pharmaceuticals-inc-02043q107) | COM | 825,000 | $248.3 million |
| [Hemab Therapeutics Hldgs Inc](https://specstream.ai/data/institutional-holders/hemab-therapeutics-hldgs-inc-423494103) | COM SHS | 3,602,093 | $132.3 million |
| [GH Research PLC](https://specstream.ai/data/institutional-holders/gh-research-plc-g3855l106) | ORDINARY SHARES | 3,333,334 | $89.6 million |
| Genmab A/S | SPONSORED ADS (call) | 3,000,000 | $82.4 million |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 123,616 | $67 million |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 3,610,000 | $66.7 million |
| [Altimmune Inc](https://specstream.ai/data/institutional-holders/altimmune-inc-02155h200) | COM NEW | 19,250,000 | $58.5 million |
| [Genedx Holdings Corp](https://specstream.ai/data/institutional-holders/genedx-holdings-corp-81663l200) | COM CL A | 700,000 | $48.1 million |
| [Harrow Inc](https://specstream.ai/data/institutional-holders/harrow-inc-415858109) | COM | 969,000 | $41.2 million |
| [Immix Biopharma Inc](https://specstream.ai/data/institutional-holders/immix-biopharma-inc-45258h106) | COM | 2,775,000 | $28.6 million |
| [Shattuck Labs Inc](https://specstream.ai/data/institutional-holders/shattuck-labs-inc-82024l103) | COM | 3,706,734 | $25.7 million |
| [Mannkind Corp](https://specstream.ai/data/institutional-holders/mannkind-corp-56400p706) | COM NEW | 6,000,000 | $25.6 million |
| [Generate Biomedicines Inc](https://specstream.ai/data/institutional-holders/generate-biomedicines-inc-370920100) | COM SHS | 1,333,815 | $22.5 million |
| [Nektar Therapeutics](https://specstream.ai/data/institutional-holders/nektar-therapeutics-640268306) | COM NEW | 300,000 | $20.9 million |
| [Olema Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/olema-pharmaceuticals-inc-68062p106) | COM | 1,500,000 | $18.8 million |
| [Kailera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kailera-therapeutics-inc-482931102) | COMMON STOCK | 700,000 | $15.4 million |
| [Kardigan Inc](https://specstream.ai/data/institutional-holders/kardigan-inc-485925101) | COM | 600,000 | $14.3 million |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 225,000 | $11.4 million |
| [Xencor Inc](https://specstream.ai/data/institutional-holders/xencor-inc-98401f105) | COM | 593,551 | $9.6 million |

## Positions exited in Q2 2026

15 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| SPDR Series Trust | ST STR SP BIOT (put) | 10,000,000 | $1.28 billion |
| Apellis Pharmaceuticals Inc | COM | 4,532,374 | $182.3 million |
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 3,158,041 | $125.4 million |
| [Bridgebio Pharma Inc](https://specstream.ai/data/institutional-holders/bridgebio-pharma-inc-10806x102) | COM | 841,445 | $62.5 million |
| Terns Pharmaceuticals Inc | COM | 1,073,877 | $56.6 million |
| [Geron Corp](https://specstream.ai/data/institutional-holders/geron-corp-374163103) | COM | 31,720,278 | $47.3 million |
| [Ani Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ani-pharmaceuticals-inc-00182c103) | COM | 600,000 | $46.1 million |
| Soleno Therapeutics Inc | COM | 1,078,710 | $36.1 million |
| Engene Holdings Inc | COM | 4,377,572 | $29.8 million |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 285,000 | $24 million |
| [Janux Therapeutics Inc](https://specstream.ai/data/institutional-holders/janux-therapeutics-inc-47103j105) | COM | 1,187,290 | $16.5 million |
| [Crescent Biopharma Inc.](https://specstream.ai/data/institutional-holders/crescent-biopharma-inc-g2545c104) | COM | 453,686 | $8.3 million |
| [Larimar Therapeutics Inc](https://specstream.ai/data/institutional-holders/larimar-therapeutics-inc-517125100) | COM | 1,500,000 | $6.8 million |
| [Cybin Inc](https://specstream.ai/data/institutional-holders/cybin-inc-23256x407) | COM NEW | 1,313,137 | $6.3 million |
| [Billiontoone Inc](https://specstream.ai/data/institutional-holders/billiontoone-inc-090168105) | CL A | 50,000 | $3.9 million |

## Also on SpecStream

- [Deep Track Capital, LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1856083/000185608326000004/0001856083-26-000004-index.htm)
- [Deep Track Capital, LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/deep-track-capital-lp-312459)
- [Largest 13F filers in Connecticut](https://specstream.ai/data/institutional-holdings/state/connecticut)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Greenwich, Connecticut

- [Investment management firms in Greenwich, Connecticut](https://specstream.ai/data/businesses/investment-management-firms/greenwich-connecticut-united-states)
- [Real estate firms in Greenwich, Connecticut](https://specstream.ai/data/businesses/real-estate-firms/greenwich-connecticut-united-states)
- [Banks and credit unions in Greenwich, Connecticut](https://specstream.ai/data/businesses/banks-and-credit-unions/greenwich-connecticut-united-states)
- [Contractors in Greenwich, Connecticut](https://specstream.ai/data/businesses/contractors/greenwich-connecticut-united-states)
- [Financial advisory firms in Greenwich, Connecticut](https://specstream.ai/data/businesses/financial-advisory-firms/greenwich-connecticut-united-states)
- [Financial services firms in Greenwich, Connecticut](https://specstream.ai/data/businesses/financial-services-firms/greenwich-connecticut-united-states)
